NCT00056992View on ClinicalTrials.gov

Testing of ADI-PEG in Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

October 31, 2003

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

ADI-PEG 20

Trial Locations (1)

Unknown

MD Anderson Cancer center, Houston

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00056992 - Testing of ADI-PEG in Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter